GSKGLAXF
13F holders, Q4 2025 (December 31)1holders −1
0new positions
1sold out
$24.54avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding GSK PLC (GLAXF) in their 13F filings, down 1 from Q3 2025. 0 opened new positions and 1 sold out. The largest holder was Aristotle Capital Management, LLC ($73.8M).
- Company
- GSK PLC
- CUSIP
- G3910J179
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $335K |
All 13F filers, Q3 2025 → Q4 2025: 17,746 shares sold, net −17,746 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Aristotle Capital Management, LLC | 0.15% | Reduce -0.1% | 3,005,874 | $73.8M |
"% of holder's portfolio" is GLAXF's weight in each manager's 13F, not the share of GSK PLC the manager owns.